Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
266 results found
2022 ∙ Fudman, D. I. Perez-Reyes, A. E. Niccum, B. A. Melmed, G. Y. Khalili, H.
Interventions to Decrease Unplanned Healthcare Utilization and Improve Quality of Care in Adults With Inflammatory Bowel Disease: A Systematic Review
Adults Older adults Pneumococcal disease Influenza Acceptance
Rating:
Not applicable
2022 ∙ Wang, Z. Chen, S. Fang, Y.
Parental Willingness and Associated Factors of Pediatric Vaccination in the Era of COVID-19 Pandemic: A Systematic Review and Meta-Analysis
All age groups Parents/caregivers Pneumococcal disease Human papillomavirus (HPV) Influenza COVID-19 Acceptance
Rating:
Not applicable
2022 ∙ Tvedskov, E. S. F. Hovmand, N. Benfield, T. Tinggaard, M.
Pneumococcal carriage among children in low and lower-middle-income countries: A systematic review
Newborn Children Low and Middle Income Countries Pneumococcal disease Coverage
Rating:
Not applicable
2022 ∙ Shao, W. Chen, X. Zheng, C. Wang, G. Zhang, B. Zhang, W.
Pneumococcal vaccination coverage and willingness in mainland China
Western Pacific China All age groups Healthcare workers Pneumococcal disease Acceptance Coverage
Rating:
Not applicable
2022 ∙ Syeed, M. S. Ghule, P. Le, L. M. Veettil, S. K. Horn, E. K. Perdrizet, J. Wasserman, M. Thakkinstian, A. Chaiyakunapruk, N.
Pneumococcal Vaccination in Children: A Systematic Review and Meta-Analysis of Cost-Effectiveness Studies
Children Pneumococcal disease Economic aspects
Rating:
Not applicable
2022 ∙ Bencina, G. Fues Wahl, H. Tsoumani, E. Salomonsson, S.
Recommendations and Health Technology Assessment (HTA) landscape evaluation for pediatric pneumococcal conjugate vaccines (PCV) in Europe: a systematic literature review
Europe Children Pneumococcal disease Economic aspects Administration
Rating:
Not applicable
2022 ∙ Sabbar, H. Mahraoui, C. Bastìas Garcià, M. Jroundi, I.
Streptococcus pneumoniae vaccination strategies and its expected impact on penicillin non-susceptibility in children under the age of five: Let's recap!
Newborn Children Pneumococcal disease Efficacy/effectiveness Safety
Rating:
Critically low
2022 ∙ Tantawichien, T. Hsu, L. Y. Zaidi, O. Bernauer, M. Du, F. Yamada, E. Kim, J. O. Sukarom, I.
Systematic literature review of the disease burden and vaccination of pneumococcal disease among adults in select Asia-Pacific areas
South-East Asia Western Pacific Adults Older adults Pneumococcal disease Coverage
Rating:
Not applicable
2022 ∙ Izurieta, P. Scherbakov, M. Nieto Guevara, J. Vetter, V. Soumahoro, L.
Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media
Newborn Children Adolescents Pneumococcal disease Efficacy/effectiveness Administration Safety
Rating:
Critically low
2022 ∙ Castrejon, M. M. Leal, I. de Jesus Pereira Pinto, T. Guzmán-Holst, A.
The impact of COVID-19 and catch-up strategies on routine childhood vaccine coverage trends in Latin America: A systematic literature review and database analysis
Americas All age groups Diphtheria Pertussis Tetanus Hepatitis B Haemophilus influenzae type B Poliomyelitis Measles Rotavirus Pneumococcal disease Tuberculosis Coverage
Rating:
Not applicable
Loading...